5AM Ventures IV, L.P.'s Net Worth

$119 Million

Estimate Recalculated May 10, 2024 03:58PM EST

Who is 5AM Ventures IV, L.P.?

5AM Ventures IV, L.P. has an estimated net worth of $119 Million. This is based on reported shares across multiple companies, which include Crinetics Pharmaceuticals, Inc., Pear Therapeutics, Inc., IDEAYA Biosciences, Inc., scPharmaceuticals Inc., Homology Medicines, Inc., and Aprea Therapeutics, Inc..

SEC CIK

5AM Ventures IV, L.P.'s CIK is 0001589315

Past Insider Trading and Trends

2019 was 5AM Ventures IV, L.P.'s most active year for acquiring shares with 20 total transactions. 5AM Ventures IV, L.P.'s most active month to acquire stocks was the month of January. 2022 was 5AM Ventures IV, L.P.'s most active year for disposing of shares, totalling 45 transactions. 5AM Ventures IV, L.P.'s most active month to dispose stocks was the month of October. 2017 saw 5AM Ventures IV, L.P. paying a total of $9,166,668.00 for 3,253,437 shares, this is the most they've acquired in one year. In 2019 5AM Ventures IV, L.P. cashed out on 6,659,533 shares for a total of $28,243,601.01, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Crinetics Pharmaceuticals, Inc. (CRNX) Snapshot price: $37.64

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-9.57%
-250.00K
$22.20
-$5,550,000.00
2.36M
Jun 21
Form 4
-5.60%
-154.84K
$24.25
-$3,754,954.14
2.61M
Mar 18
Form 4
-14.35%
-464.83K
—
—
2.77M
Feb 20
Form 4
-7.49%
-262.15K
$21.88
-$5,734,596.87
3.24M
Jan 22
Form 4
+103.40%
3.5M
$17.00
$1,955,000.00
6.88M
Jul 20
Form 3
—
0
—
—
0
No matching records found

Pear Therapeutics, Inc. (PEARQ) Snapshot price: $0.0002

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-98.81%
-16.54M
$0.12
-$1,985,293.56
200K
Apr 10
Form 4
-0.78%
-105.28K
$2.74
-$288,267.28
13.37M
Nov 11 - Nov 15
Form 4
-0.40%
-54.21K
$2.77
-$150,095.68
13.48M
Oct 31 - Nov 2
Form 4
-3.96%
-558.17K
$1.88
-$1,047,321.73
13.53M
Sep 14 - Sep 16
Form 4
-5.18%
-770.00K
$2.05
-$1,581,834.98
14.09M
Sep 6 - Sep 8
Form 4
-2.62%
-400.00K
$1.65
-$660,059.58
14.86M
Aug 16 - Aug 18
Form 3
—
0
—
—
0
No matching records found

IDEAYA Biosciences, Inc. (IDYA) Snapshot price: $43.49

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-23.10%
-800.00K
$13.66
-$10,928,000.00
2.66M
Nov 11
Form 4
+103.84%
3.15M
$10.00
$7,500,000.00
6.18M
May 28
Form 3
—
0
—
—
0
No matching records found

scPharmaceuticals Inc. (SCPH) Snapshot price: $5.32

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-17.99%
-600.00K
$4.15
-$2,488,906.62
2.73M
Oct 6 - Oct 10
Form 4
-6.36%
-226.62K
$4.84
-$1,096,953.44
3.33M
Sep 6 - Sep 7
Form 4
-7.05%
-270.00K
$5.00
-$1,350,000.00
3.56M
Apr 11
Form 4
∞
3.25M
$14.00
—
3.25M
Nov 21
Form 3
—
0
—
—
0
No matching records found

Homology Medicines, Inc. (FIXX) Snapshot price: $0.715

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-9.93%
-500.00K
$12.82
-$6,410,000.00
4.54M
Dec 22
Form 4
-9.03%
-500.00K
$12.25
-$6,125,914.99
5.04M
Dec 14
Form 4
-10.00%
-615.00K
$21.47
-$13,204,050.00
5.54M
May 16
Form 4
-0.25%
-15.57K
$26.01
-$405,029.44
6.15M
Dec 10
Form 4
-0.48%
-29.68K
$20.04
-$594,708.55
6.17M
Nov 23
Form 4
-7.82%
-525.90K
$20.20
-$10,623,180.00
6.2M
Nov 16
Form 4
+405.40%
5.39M
—
—
6.72M
Apr 2
Form 3
—
0
—
—
0
No matching records found